Cargando…
First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study
BACKGROUND: The targeted therapy cetuximab [directed at the epidermal growth factor receptor (EGFR)] in combination with 5-fluorouracil and platinum-based chemotherapy (the EXTREME regimen) has shown substantial efficacy for patients with recurrent or metastatic squamous cell carcinoma of the head a...
Autores principales: | Falco, Agustín, Leiva, Mariano, Blanco, Albano, Cefarelli, Guido, Rodriguez, Andrés, Melo, Juan, Cayol, Federico, Rizzo, Manglio Miguel, Sola, Alejandro, Rodríguez Montani, Hernán, Chacon, Matías, Enrico, Diego, Waisberg, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894270/ https://www.ncbi.nlm.nih.gov/pubmed/35316930 http://dx.doi.org/10.5306/wjco.v13.i2.147 |
Ejemplares similares
-
Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
por: Suzuki, Kosuke, et al.
Publicado: (2021) -
Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
por: Lam, Ka-On, et al.
Publicado: (2019) -
Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
por: Isaksson, Jenny, et al.
Publicado: (2021) -
Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019) -
Decreased cross-sectional muscle area in male patients with clear cell renal cell carcinoma and peritumoral collateral vessels
por: Greco, Federico, et al.
Publicado: (2022)